Human adrenal LH/hCG receptors and what they could mean for adrenal physiology and pathology

Molecular and Cellular Endocrinology
C V Rao

Abstract

Although the research on the potential regulation of human adrenal cortex by LH and hCG is still in its infancy, the available evidence supports the presence of very low levels of LH/hCG receptors in entire zona reticularis and deeper part of zona fasciculata. The activation of these receptors may lead to an increased secretion of androgens and/or cortisol. The same chronically elevated levels, along with unknown genetic and epigenetic changes, may also lead to the formation of tumors that can secrete all three major classes of adrenal steroid hormones. As shown in murine models, the increased receptor levels often seen in tumors, are probably caused by elevated LH/hCG levels. However, the elevated LH/hCG levels or their receptors alone may not be sufficient for the development of adrenal pathology. Therefore, further studies to advance our current understanding on the pathophysiology of human adrenal hCG/LH receptors are required.

References

May 1, 1978·The Journal of Clinical Endocrinology and Metabolism·M Serón-FerréR B Jaffe
Jan 1, 1975·Acta Endocrinologica·M Blichert-ToftR Albrechtsen
May 1, 1977·Journal of Steroid Biochemistry·R B JaffeC Korenbrot
Apr 1, 1991·The Journal of Endocrinology·T J McKenna, S K Cunningham
Oct 11, 1973·The New England Journal of Medicine·E E WerkL Kalejs
Jan 1, 1980·Endocrine Reviews·L N Parker, W D Odell
Jan 1, 1981·Annual Review of Biochemistry·J G Pierce, T F Parsons
May 1, 1984·The Journal of Clinical Endocrinology and Metabolism·G E HofmannJ S Sanfilippo
Apr 1, 1994·Molecular and Cellular Endocrinology·W E RaineyJ I Mason
Dec 29, 1995·Annals of the New York Academy of Sciences·P J Hornsby
Jun 1, 1996·The Journal of Clinical Endocrinology and Metabolism·J E PabonC V Rao
Jan 10, 2003·The Journal of Clinical Endocrinology and Metabolism·Mark O GoodarziAndre J Van Herle
Feb 7, 2004·The Journal of Clinical Endocrinology and Metabolism·M A AbdallahCh V Rao
Dec 8, 2005·The Journal of Clinical Endocrinology and Metabolism·Karla Saner-AmighWilliam E Rainey
May 27, 2006·European Journal of Endocrinology·Maria AlevizakiIlpo Huhtaniemi
Jan 9, 2007·Molecular and Cellular Endocrinology·Helka ParviainenMarkku Heikinheimo
Aug 12, 2008·Trends in Endocrinology and Metabolism : TEM·Sophie BernichteinIlpo Huhtaniemi

❮ Previous
Next ❯

Citations

Jun 4, 2015·Endocrinology and Metabolism Clinics of North America·Deirdre Cocks EschlerRachel Pessah-Pollack
Dec 25, 2013·Molecular and Cellular Endocrinology·Janet Choi, Johan Smitz
Jul 6, 2016·Frontiers in Neuroscience·Gavin P Vinson
Oct 5, 2011·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J C Lovejoy, M Sasagawa

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Cancer Epigenetics & Methyl-CpG (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. Here is the latest research on cancer epigenetics and methyl-CpG binding proteins including ZBTB38.

Cancer Epigenetics

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cell Signaling & Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. This feed covers the latest research on signaling and epigenetics in cell growth and cancer.

Cancer Epigenetics (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. Here is the latest research on cancer epigenetics.

Cancer Epigenetics & Metabolism (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may or may not provide advantages for the cancer cells. This feed focuses on the relationship between cell metabolism, epigenetics and tumor differentiation.

Cancer Epigenetics and Senescence (Keystone)

Epigenetic changes are present and dysregulated in many cancers, including DNA methylation, non-coding RNA segments and post-translational protein modifications. The epigenetic changes may be involved in regulating senescence in cancer cells. This feed captures the latest research on cancer epigenetics and senescence.